Phase 2 Study of Dacomitinib in NSCLC

Clinical trial NCT04027647 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04027647
Sponsor: National Cancer Centre, Singapore
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

NSCLC Stage IIIB NSCLC Stage IIIC NSCLC Stage IV Recurrent NSCLC EGFR Positive Non-Small Cell Lung Cancer

Start date: 2019-09-11
Primary completion: 2026-03-31
Enrollment: 118

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.